These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

628 related articles for article (PubMed ID: 26272765)

  • 1. Paclitaxel tumor priming promotes delivery and transfection of intravenous lipid-siRNA in pancreatic tumors.
    Wang J; Lu Z; Wang J; Cui M; Yeung BZ; Cole DJ; Wientjes MG; Au JL
    J Control Release; 2015 Oct; 216():103-10. PubMed ID: 26272765
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor priming enhances siRNA delivery and transfection in intraperitoneal tumors.
    Wang J; Lu Z; Yeung BZ; Wientjes MG; Cole DJ; Au JL
    J Control Release; 2014 Mar; 178():79-85. PubMed ID: 24462901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravenous siRNA Silencing of Survivin Enhances Activity of Mitomycin C in Human Bladder RT4 Xenografts.
    Cui M; Au JL; Wientjes MG; O'Donnell MA; Loughlin KR; Lu Z
    J Urol; 2015 Jul; 194(1):230-7. PubMed ID: 25681288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Paclitaxel tumor-priming enhances siRNA delivery and transfection in 3-dimensional tumor cultures.
    Wong HL; Shen Z; Lu Z; Wientjes MG; Au JL
    Mol Pharm; 2011 Jun; 8(3):833-40. PubMed ID: 21417439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multifunctional Polymeric Micelles Co-loaded with Anti-Survivin siRNA and Paclitaxel Overcome Drug Resistance in an Animal Model of Ovarian Cancer.
    Salzano G; Navarro G; Trivedi MS; De Rosa G; Torchilin VP
    Mol Cancer Ther; 2015 Apr; 14(4):1075-84. PubMed ID: 25657335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinspired tumor-homing nanoplatform for co-delivery of paclitaxel and siRNA-E7 to HPV-related cervical malignancies for synergistic therapy.
    Xu C; Liu W; Hu Y; Li W; Di W
    Theranostics; 2020; 10(7):3325-3339. PubMed ID: 32194871
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cationic solid lipid nanoparticles for co-delivery of paclitaxel and siRNA.
    Yu YH; Kim E; Park DE; Shim G; Lee S; Kim YB; Kim CW; Oh YK
    Eur J Pharm Biopharm; 2012 Feb; 80(2):268-73. PubMed ID: 22108492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth inhibition and chemo-radiosensitization of head and neck squamous cell carcinoma (HNSCC) by survivin-siRNA lentivirus.
    Khan Z; Khan AA; Prasad GB; Khan N; Tiwari RP; Bisen PS
    Radiother Oncol; 2016 Feb; 118(2):359-68. PubMed ID: 26747757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A study of the suppressive effect on human pancreatic adenocarcinoma cell proliferation and angiogenesis by stable plasmid-based siRNA silencing of c-Src gene expression.
    Zhao X; Li DC; Zhao H; Li Z; Wang JX; Zhu DM; Zhou J; Cen JN
    Oncol Rep; 2012 Mar; 27(3):628-36. PubMed ID: 22200682
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of dendrimer-nanovector-mediated small interfering RNA delivery to target Akt with the clinical anticancer drug paclitaxel for effective and potent anticancer activity in treating ovarian cancer.
    Kala S; Mak AS; Liu X; Posocco P; Pricl S; Peng L; Wong AS
    J Med Chem; 2014 Mar; 57(6):2634-42. PubMed ID: 24592939
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biocompatible AIEgen/p-glycoprotein siRNA@reduction-sensitive paclitaxel polymeric prodrug nanoparticles for overcoming chemotherapy resistance in ovarian cancer.
    Wu J; Wang Q; Dong X; Xu M; Yang J; Yi X; Chen B; Dong X; Wang Y; Lou X; Xia F; Wang S; Dai J
    Theranostics; 2021; 11(8):3710-3724. PubMed ID: 33664857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel biodegradable lipid nano complex for siRNA delivery significantly improving the chemosensitivity of human colon cancer stem cells to paclitaxel.
    Liu C; Zhao G; Liu J; Ma N; Chivukula P; Perelman L; Okada K; Chen Z; Gough D; Yu L
    J Control Release; 2009 Dec; 140(3):277-83. PubMed ID: 19699770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of lung cancer multidrug resistance by pH-responsive micelleplexes mediating co-delivery of siRNA and paclitaxel.
    Yu H; Xu Z; Chen X; Xu L; Yin Q; Zhang Z; Li Y
    Macromol Biosci; 2014 Jan; 14(1):100-9. PubMed ID: 23966347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anisamide-targeted PEGylated gold nanoparticles designed to target prostate cancer mediate: Enhanced systemic exposure of siRNA, tumour growth suppression and a synergistic therapeutic response in combination with paclitaxel in mice.
    Luan X; Rahme K; Cong Z; Wang L; Zou Y; He Y; Yang H; Holmes JD; O'Driscoll CM; Guo J
    Eur J Pharm Biopharm; 2019 Apr; 137():56-67. PubMed ID: 30779980
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1-IRIS inactivation overcomes paclitaxel resistance in triple negative breast cancers.
    Blanchard Z; Paul BT; Craft B; ElShamy WM
    Breast Cancer Res; 2015 Jan; 17(1):5. PubMed ID: 25583261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intraperitoneal administration of a small interfering RNA targeting nuclear factor-kappa B with paclitaxel successfully prolongs the survival of xenograft model mice with peritoneal metastasis of gastric cancer.
    Inoue M; Matsumoto S; Saito H; Tsujitani S; Ikeguchi M
    Int J Cancer; 2008 Dec; 123(11):2696-701. PubMed ID: 18798274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cluster of Differentiation 44 Targeted Hyaluronic Acid Based Nanoparticles for MDR1 siRNA Delivery to Overcome Drug Resistance in Ovarian Cancer.
    Yang X; Iyer AK; Singh A; Milane L; Choy E; Hornicek FJ; Amiji MM; Duan Z
    Pharm Res; 2015 Jun; 32(6):2097-109. PubMed ID: 25515492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. siRNA delivery to lung-metastasized tumor by systemic injection with cationic liposomes.
    Hattori Y; Nakamura A; Arai S; Kawano K; Maitani Y; Yonemochi E
    J Liposome Res; 2015; 25(4):279-86. PubMed ID: 25543847
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-penetrating codelivery of siRNA and paclitaxel with ultrasound-responsive nanobubbles hetero-assembled from polymeric micelles and liposomes.
    Yin T; Wang P; Li J; Wang Y; Zheng B; Zheng R; Cheng D; Shuai X
    Biomaterials; 2014 Jul; 35(22):5932-43. PubMed ID: 24746965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell-penetrating peptide mimicking polymer-based combined delivery of paclitaxel and siRNA for enhanced tumor growth suppression.
    Jang YL; Yun UJ; Lee MS; Kim MG; Son S; Lee K; Chae SY; Lim DW; Kim HT; Kim SH; Jeong JH
    Int J Pharm; 2012 Sep; 434(1-2):488-93. PubMed ID: 22613208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.